OppenheimerFunds’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $52.7M | Sell |
319,967
-614,828
| -66% | -$109M | 0.07% | 302 |
|
|
2018
Q4 | $176M | Sell |
934,795
-815,363
| -47% | -$151M | 0.25% | 104 |
|
|
2018
Q3 | $298M | Sell |
1,750,158
-143,313
| -8% | -$24.1M | 0.35% | 73 |
|
|
2018
Q2 | $310M | Sell |
1,893,471
-78,444
| -4% | -$12.8M | 0.37% | 65 |
|
|
2018
Q1 | $319M | Sell |
1,971,915
-258,218
| -12% | -$41.1M | 0.4% | 56 |
|
|
2017
Q4 | $326M | Sell |
2,230,133
-171,999
| -7% | -$24.5M | 0.39% | 58 |
|
|
2017
Q3 | $326M | Sell |
2,402,132
-76,845
| -3% | -$9.71M | 0.4% | 64 |
|
|
2017
Q2 | $310M | Sell |
2,478,977
-371,496
| -13% | -$44.4M | 0.38% | 69 |
|
|
2017
Q1 | $339M | Sell |
2,850,473
-1,781,128
| -38% | -$214M | 0.41% | 65 |
|
|
2016
Q4 | $534M | Buy |
4,631,601
+708,845
| +18% | +$78.9M | 0.68% | 18 |
|
|
2016
Q3 | $410M | Sell |
3,922,756
-948,193
| -19% | -$99M | 0.51% | 41 |
|
|
2016
Q2 | $474M | Sell |
4,870,949
-23,169
| -0.5% | -$2.19M | 0.62% | 30 |
|
|
2016
Q1 | $470M | Buy |
4,894,118
+177,308
| +4% | +$16.1M | 0.62% | 31 |
|
|
2015
Q4 | $427M | Sell |
4,716,810
-367,334
| -7% | -$34.6M | 0.54% | 41 |
|
|
2015
Q3 | $472M | Buy |
5,084,144
+746,946
| +17% | +$71M | 0.64% | 26 |
|
|
2015
Q2 | $404M | Buy |
4,337,198
+366,586
| +9% | +$34.2M | 0.46% | 49 |
|
|
2015
Q1 | $376M | Sell |
3,970,612
-364,050
| -8% | -$33.7M | 0.42% | 57 |
|
|
2014
Q4 | $384M | Sell |
4,334,662
-624,920
| -13% | -$53M | 0.43% | 55 |
|
|
2014
Q3 | $397M | Sell |
4,959,582
-95,176
| -2% | -$7.17M | 0.44% | 56 |
|
|
2014
Q2 | $359M | Sell |
5,054,758
-198,169
| -4% | -$13.9M | 0.4% | 64 |
|
|
2014
Q1 | $389M | Buy |
5,252,927
+3,475,992
| +196% | +$262M | 0.46% | 48 |
|
|
2013
Q4 | $139M | Buy |
1,776,935
+61,017
| +4% | +$4.78M | 0.17% | 161 |
|
|
2013
Q3 | $127M | Sell |
1,715,918
-483,430
| -22% | -$35.6M | 0.17% | 158 |
|
|
2013
Q2 | $167M | Buy |
+2,199,348
| New | +$144M | 0.24% | 109 |
|
Other funds holding CME
